SGM - Transition to a Charitable Trust: Unlocking Greater Potential for ANZMES
The Opportunity: With the new Incorporated Societies Act 2022 requiring re-registration by April 2026, ANZMES has the unique opportunity to optimise our organisational structure. Currently, as an Incorporated Society, member involvement is required for major decisions, but participation is low, with less than 5% of those affected by ME/CFS in NZ engaged. We propose transitioning to a Charitable Trust model which allows for more agile governance, aligning with our strategic plan to better serve the growing ME/CFS and long COVID community.
Why a Charitable Trust? We value our members' feedback, but we understand that participating in AGMs and surveys can be challenging, especially for those unwell. The new Charitable Trust Board (CTB) structure removes this pressure by eliminating the need for member input on such matters. The key benefits of a CTB are as follows:
●
Additional Revenue Streams: Allows us to generate funds for charitable purposes. By diversifying income, we can invest more in research and initiatives, strengthening our impact as the leading National Advisory and securing our vision for the future. This transition also aligns with best governance practices, providing a strong foundation for growth and success.
●
Reduced Administrative Burden: CTB’s have simpler reporting requirements, allowing us to focus on our core objectives as the National Advisory on ME/CFS. The new Incorporated Societies Act 2022 increases administrative complexity, but a Charitable Trust model offers straightforward governance and compliance, reducing overhead.
●
Efficient Decision-Making: Centralised decision-making by an elected board allows us to respond quickly and effectively to opportunities and challenges, enhancing our mission without the need for extensive member approvals.
●
Reduced Quorum Requirements: Charitable Trusts eliminate the need for member participation resolving the challenge of low AGM attendance and enabling more effective governance.
Transition Plan: If approved, your role will shift from 'members' to 'supporters,' acknowledging your valuable contributions. The transition will unfold as follows, with a focus on open communication:
●
Voting: Members will vote on this transition via mail or online form and during the SGM/AGM in November.
●
Trust Deed Development: A pro bono lawyer will develop the Trust Deed to replace our Constitution.
●
Establishment: The Charitable Trust will be formally established, followed by the recruitment of the Trust Board, and the winding up of the Incorporated Society.
NOTICE OF SPECIAL GENERAL MEETING
ASSOCIATED NEW ZEALAND MYALGIC ENCEPHALOMYELITIS SOCIETY INC.
Notice is hereby given that an Online (via ZOOM) Special General Meeting has been called for
Saturday, 2nd November 2024 starting at 10.30am
Resolution
- Ordinary resolutions shall be determined by a simple majority vote.
- Your committee has indicated that they will vote in favour of the resolution.
The motion put to the ANZMES membership:
It is proposed that ASSOCIATED NEW ZEALAND MYALGIC ENCEPHALOMYELITIS SOCIETY INC will transition to a charitable trust board.
[removed section with passcode]
Reason transition to a charitable trust board:
With the new Incorporated Societies Act 2022 requiring re-registration by April 2026, ANZMES has the unique opportunity to optimise our organisational structure. Currently, as an Incorporated Society, member involvement is required for major decisions, but participation is low, with less than 5% of those affected by ME/CFS in NZ engaged. We propose transitioning to a Charitable Trust model which allows for more agile governance, aligning with our strategic plan to better serve the growing ME/CFS and long COVID community.
________________________________________________________________________
Please note , if you unable to attend the online meeting in person you can vote by post or online form, votes to be received NO later than 5pm Thursday, 29th October 2024
[removed section with voting form]